Precision medicine treatment in older AML: Results of Beat AML master trial
Precision medicine treatment in older AML: Results of Beat AML master trial
Identifying prognostic constellations of driver mutations in acute myeloid leukaemia and myelodysplastic syndromes
Exploring the pathogenesis of AML and myelodysplastic syndromes using genome and transcriptome sequencing
Addressing the treatment gap for patients with relapsed/refractory primary systemic AL amyloidosis: TOURMALINE-AL1 trial results
Multiple myeloma: Anti-BCMA BiTE AMG 701 shows preclinical promise
Evaluating emerging mutations in patients with acute myeloid leukaemia who relapsed while receiving gilteritinib therapy in the ADMIRAL trial
Maintenance decitabine after intensive therapy for AML in older FLT3-ITD-negative patients
Dual-targeted antibody mosunetuzumab elicits durable responses in poor-prognosis non-Hodgkin Lymphoma patients
The importance of proper geriatric classification for haematological malignancies
Should breast and colorectal cancer screening be carried out in older adults?
Cancer early detection: Strategies, barriers and solutions
The future of cancer care in India